Back to REGN
ProShare Advisors LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$88.7M
Q3 2026
Peak value
$142.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $76M |
| Q4 2025 | $142.2M |
| Q1 2026 | $117.7M |
| Q2 2026 | $74.4M |
| Q3 2026 | $88.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $88.7M | 117.0K | — | — |
| Q2 2026 | $74.4M | 119.2K | — | — |
| Q1 2026 | $117.7M | 152.4K | — | — |
| Q4 2025 | $142.2M | 184.3K | — | — |
| Q3 2025 | $76M | 135.2K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B